DNA Therapeutics is at the forefront of medical approaches to DNA repair Induced cancer resistance to therapies. It develops 1st-in-class targeted therapeutics addressing the fact that radiotherapy and chemotherapy often fail in the treatment of advanced cancers, due to tumor’s enhanced capacity to repair DNA lesions caused by the DNA damaging treatments that are radiotherapy and chemotherapy. It develops its original siDNA (signal interfering DNA) technology platform and innovative targeting drugs by interfering with DNA damage repair pathways - proven targets in cancer therapies.